Business · 19/05/2014Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for ELELYSO Patent Extension
Summary
The Food and Drug Administration has officially confirmed the regulatory review period for ELELYSO, a human drug product, in accordance with federal regulations, following a patent extension application submitted to the Department of Commerce.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →